Pre-Exposure Prophylaxis PrEP

More documents

Recommendations

Info

1 December 2012
THAILANDAdult (15-49 years) HIV <strong>Pre</strong>valenceThailand 1990-2010HIV Incidence, All AgeThailand 1990-2010%1.3%9,700yearyear
Page 1: Narin Hiransuthikul MD, PhDDep. Pre
Page 5 and 6: December 2009
Page 7 and 8: ้วิธีการต่า
Page 9 and 10: ่่้การใช้ยา
Page 11 and 12: • The ongoing use of one or two a
Page 14: Miller CJ, et al. J Virology 2005 :
Page 17 and 18: WhyTenofovirand/orEmtricitabine?
Page 19 and 20: Tenofovir (Viread) for PrEP• Nucl
Page 21 and 22: เพร็พแบบกินOr
Page 23 and 24: ีื่การศึกษา
Page 25 and 26: ความสัมพันธ
Page 27 and 28: ความท้าทายอ
Page 29 and 30: PrEP would be an addition to, not a
Page 31 and 32: HIVPost-Exposure Prophylaxis (PEP)
Page 33: Last updated Jan 21, 2005© World H
Page 36 and 37: ความเสี่ยงใ
Page 38 and 39: Definitely Potentially Not infectio
Page 40 and 41: Risk of HIV Occupational Transmissi
Page 42 and 43: Estimated Pathogen‐Specific Seroc
Page 44 and 45: Other Cofactors• Source HIV viral
Page 46 and 47: 1. First aids2. Counseling & Assess
Page 48 and 49: HIV PEP• Current multidrug regime
Page 50 and 51: Indications for Occupational PEP*So
Page 52 and 53:
Recommended PEP RegimensBASIC REGIM
Page 55 and 56:
Preferred regimenARV regimens forHI
Page 57 and 58:
Follow-up of HCP exposed to known o
Page 59 and 60:
ููุตารางที่ 1
Page 61 and 62:
ตารางที่ 2.2 กา
Page 63 and 64:
Recommended PEP RegimensBASIC REGIM
Page 65:
ARV Regimens for HIV PEP• Raltegr
Page 68 and 69:
Recommended Laboratory Evaluation f
Page 70:
สรุปเรื่อง เ
show all

Pre-Exposure Prophylaxis PrEP

Create successful ePaper yourself

Delete template?

Save as template?